ArticleAntonie van Leeuwenhoek2026
Antioxidant capacity, and probiotic properties of Enterococcus faecium strains isolated from raw milk of indigenous brown atlas cows.
Article in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, we investigated the safety characteristics and probiotic proprieties of Enterococcus faecium (E. Faecium) strains isolated from raw milk of indigenous Brown Atlas cows reared in the Tafoughalt region (Berkane, Morocco). Eleven isolates were identified as E. faecium by 16S rRNA gene sequencing and subjected to an in-vitro evaluation approach including antibiotic susceptibility, safety related enzymatic activities, tolerance to gastrointestinal stress conditions, antioxidant capacity, and antibacterial activity against selected foodborne pathogens. All isolates were susceptible to clinically relevant antibiotics, such as ampicillin, vancomycin, gentamicin, tetracycline, and chloramphenicol, and none exhibited evidence of acquired or transferable antibiotic resistance. Safety assessment revealed the absence of haemolytic, DNase, and gelatinase activities in all strains. The isolates demonstrated marked tolerance to acidic conditions (pH 2.0-3.0) and bile salt concentrations (0.15%-0.30%), indicating their ability to survive simulated gastrointestinal environments. All strains inhibited the growth of Staphylococcus aureus ATCC 29213 in a strain and concentration dependent manner, while moderate inhibitory activity was observed against Escherichia coli ATCC 25922. Neutralisation and enzymatic treatments indicated that the antibacterial activity was primarily associated with organic acid production and, to a lesser extent, with proteinaceous compounds, suggesting the involvement of bacteriocin like substances. In addition, the isolates exhibited moderate, strain dependent antioxidant activity, ranging from approximately 15% to 27%. Among the evaluated strains, E. faecium EF89 displayed the most favourable combination of safety attributes and probiotic properties. Collectively, these results show that E. faecium strains isolated from Brown Atlas cow milk in Eastern Morocco are safe and promising candidates for use in functional foods and food biopreservation, supporting the valorisation of indigenous dairy resources.
Indexed as
Identifiers
42115441What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.